e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Advancements in pathobiology of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Apoptosis of circulating and BALF lymphocytes of patients with lung cancer
J. Domagala-Kulawik, G. Hoser, R. Chazan (Warsaw, Poland)
Source:
Annual Congress 2004 - Advancements in pathobiology of respiratory diseases
Session:
Advancements in pathobiology of respiratory diseases
Session type:
Poster Discussion
Number:
397
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Domagala-Kulawik, G. Hoser, R. Chazan (Warsaw, Poland). Apoptosis of circulating and BALF lymphocytes of patients with lung cancer. Eur Respir J 2004; 24: Suppl. 48, 397
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Programmed death-1 T cells in lung cancer- a comparison of BALF cells from affected lung to healthy lung and peripheral blood
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
EpCAM-positive circulating cells in lung cancer patients
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Apoptosis of bronchoalveolar lavage lymphocytes in hypersensitivity pneumonitis
Source: Eur Respir J 2003; 21: 225-231
Year: 2003
Non-compartmentalisation of inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients
Source: Eur Respir J 2005; 26: Suppl. 49, 176s
Year: 2005
The expression and clinical significance of PD-L1
+
CD68
+
macrophages in peripheral blood mononuclear cells of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 356s
Year: 2004
Tumor markers in bronchial secretions and serum in patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 76s
Year: 2004
Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Cellular changes in BAL fluid may reflect immunity in patients with lung cancer
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005
a
E
b7
integrin (CD103-
b7
) expression in bronchoalveolar T lymphocytes in interstitial lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 576s
Year: 2007
Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 529s
Year: 2004
DNA damage in lymphocytes from COPD patients with and without lung cancer
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Serum tumor markers in lung cancer patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
Evaluation expression of miR-146a and miR-155 and inflammatory cytokines in blood of non-small cell lung cancer patients
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept